394 related articles for article (PubMed ID: 30316868)
1. Improved assays to measure and characterize the inducible HIV reservoir.
Massanella M; Yek C; Lada SM; Nakazawa M; Shefa N; Huang K; Richman DD
EBioMedicine; 2018 Oct; 36():113-121. PubMed ID: 30316868
[TBL] [Abstract][Full Text] [Related]
2. Measuring the Inducible, Replication-Competent HIV Reservoir Using an Ultra-Sensitive p24 Readout, the Digital ELISA Viral Outgrowth Assay.
Stuelke EL; James KS; Kirchherr JL; Allard B; Baker C; Kuruc JD; Gay CL; Margolis DM; Archin NM
Front Immunol; 2020; 11():1971. PubMed ID: 32849659
[TBL] [Abstract][Full Text] [Related]
3. Measuring replication competent HIV-1: advances and challenges in defining the latent reservoir.
Wang Z; Simonetti FR; Siliciano RF; Laird GM
Retrovirology; 2018 Feb; 15(1):21. PubMed ID: 29433524
[TBL] [Abstract][Full Text] [Related]
4. Paucity of Intact Non-Induced Provirus with Early, Long-Term Antiretroviral Therapy of Perinatal HIV Infection.
Rainwater-Lovett K; Ziemniak C; Watson D; Luzuriaga K; Siberry G; Petru A; Chen Y; Uprety P; McManus M; Ho YC; Lamers SL; Persaud D
PLoS One; 2017; 12(2):e0170548. PubMed ID: 28178277
[TBL] [Abstract][Full Text] [Related]
5. A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals.
Procopio FA; Fromentin R; Kulpa DA; Brehm JH; Bebin AG; Strain MC; Richman DD; O'Doherty U; Palmer S; Hecht FM; Hoh R; Barnard RJ; Miller MD; Hazuda DJ; Deeks SG; Sékaly RP; Chomont N
EBioMedicine; 2015 Aug; 2(8):874-83. PubMed ID: 26425694
[TBL] [Abstract][Full Text] [Related]
6. Low Inducibility of Latent Human Immunodeficiency Virus Type 1 Proviruses as a Major Barrier to Cure.
Siliciano JD; Siliciano RF
J Infect Dis; 2021 Feb; 223(12 Suppl 2):13-21. PubMed ID: 33586775
[TBL] [Abstract][Full Text] [Related]
7. Measuring HIV Persistence on Antiretroviral Therapy.
Horsburgh BA; Palmer S
Adv Exp Med Biol; 2018; 1075():265-284. PubMed ID: 30030797
[TBL] [Abstract][Full Text] [Related]
8. Assessing the Suitability of Next-Generation Viral Outgrowth Assays to Measure Human Immunodeficiency Virus 1 Latent Reservoir Size.
Stone M; Rosenbloom DIS; Bacchetti P; Deng X; Dimapasoc M; Keating S; Bakkour S; Richman DD; Mellors JW; Deeks SG; Lai J; Beg S; Siliciano JD; Pagliuzza A; Chomont N; Lackman-Smith C; Ptak RG; Busch MP
J Infect Dis; 2021 Oct; 224(7):1209-1218. PubMed ID: 32147687
[TBL] [Abstract][Full Text] [Related]
9. Effector memory differentiation increases detection of replication-competent HIV-l in resting CD4+ T cells from virally suppressed individuals.
Wonderlich ER; Subramanian K; Cox B; Wiegand A; Lackman-Smith C; Bale MJ; Stone M; Hoh R; Kearney MF; Maldarelli F; Deeks SG; Busch MP; Ptak RG; Kulpa DA
PLoS Pathog; 2019 Oct; 15(10):e1008074. PubMed ID: 31609991
[TBL] [Abstract][Full Text] [Related]
10. Inducible HIV RNA transcription assays to measure HIV persistence: pros and cons of a compromise.
Plantin J; Massanella M; Chomont N
Retrovirology; 2018 Jan; 15(1):9. PubMed ID: 29343255
[TBL] [Abstract][Full Text] [Related]
11. VIP-SPOT: an Innovative Assay To Quantify the Productive HIV-1 Reservoir in the Monitoring of Cure Strategies.
Puertas MC; Bayón-Gil Á; Garcia-Guerrero MC; Salgado M; Urrea V; Morón-López S; Peña R; Jiménez-Moyano E; Clotet B; Prado JG; Martinez-Picado J
mBio; 2021 Jun; 12(3):e0056021. PubMed ID: 34154408
[TBL] [Abstract][Full Text] [Related]
12. Measuring integrated HIV DNA ex vivo and in vitro provides insights about how reservoirs are formed and maintained.
Pinzone MR; O'Doherty U
Retrovirology; 2018 Feb; 15(1):22. PubMed ID: 29452580
[TBL] [Abstract][Full Text] [Related]
13. Quantitation of the latent HIV-1 reservoir from the sequence diversity in viral outgrowth assays.
Poon AFY; Prodger JL; Lynch BA; Lai J; Reynolds SJ; Kasule J; Capoferri AA; Lamers SL; Rodriguez CW; Bruno D; Porcella SF; Martens C; Quinn TC; Redd AD
Retrovirology; 2018 Jul; 15(1):47. PubMed ID: 29976219
[TBL] [Abstract][Full Text] [Related]
14. Reduced Frequency of Cells Latently Infected With Replication-Competent Human Immunodeficiency Virus-1 in Virally Suppressed Individuals Living in Rakai, Uganda.
Prodger JL; Lai J; Reynolds SJ; Keruly JC; Moore RD; Kasule J; Kityamuweesi T; Buule P; Serwadda D; Nason M; Capoferri AA; Porcella SF; Siliciano RF; Redd AD; Siliciano JD; Quinn TC
Clin Infect Dis; 2017 Oct; 65(8):1308-1315. PubMed ID: 28535179
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies.
Eriksson S; Graf EH; Dahl V; Strain MC; Yukl SA; Lysenko ES; Bosch RJ; Lai J; Chioma S; Emad F; Abdel-Mohsen M; Hoh R; Hecht F; Hunt P; Somsouk M; Wong J; Johnston R; Siliciano RF; Richman DD; O'Doherty U; Palmer S; Deeks SG; Siliciano JD
PLoS Pathog; 2013 Feb; 9(2):e1003174. PubMed ID: 23459007
[TBL] [Abstract][Full Text] [Related]
16. Modeling HIV-1 Latency Using Primary CD4
Takata H; Kessing C; Sy A; Lima N; Sciumbata J; Mori L; Jones RB; Chomont N; Michael NL; Valente S; Trautmann L
J Virol; 2019 Jun; 93(11):. PubMed ID: 30918072
[TBL] [Abstract][Full Text] [Related]
17. Assays to Measure Latency, Reservoirs, and Reactivation.
Siliciano JD; Siliciano RF
Curr Top Microbiol Immunol; 2018; 417():23-41. PubMed ID: 29071475
[TBL] [Abstract][Full Text] [Related]
18. Assessing intra-lab precision and inter-lab repeatability of outgrowth assays of HIV-1 latent reservoir size.
Rosenbloom DIS; Bacchetti P; Stone M; Deng X; Bosch RJ; Richman DD; Siliciano JD; Mellors JW; Deeks SG; Ptak RG; Hoh R; Keating SM; Dimapasoc M; Massanella M; Lai J; Sobolewski MD; Kulpa DA; Busch MP;
PLoS Comput Biol; 2019 Apr; 15(4):e1006849. PubMed ID: 30978183
[TBL] [Abstract][Full Text] [Related]
19. A targeted reactivation of latent HIV-1 using an activator vector in patient samples from acute infection.
Mann JFS; Pankrac J; Klein K; McKay PF; King DFL; Gibson R; Wijewardhana CN; Pawa R; Meyerowitz J; Gao Y; Canaday DH; Avino M; Poon AFY; Foster C; Fidler S; Shattock RJ; Arts EJ
EBioMedicine; 2020 Sep; 59():102853. PubMed ID: 32654992
[TBL] [Abstract][Full Text] [Related]
20. Ultrasensitive HIV-1 p24 Assay Detects Single Infected Cells and Differences in Reservoir Induction by Latency Reversal Agents.
Passaes CPB; Bruel T; Decalf J; David A; Angin M; Monceaux V; Muller-Trutwin M; Noel N; Bourdic K; Lambotte O; Albert ML; Duffy D; Schwartz O; Sáez-Cirión A
J Virol; 2017 Mar; 91(6):. PubMed ID: 28077644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
